Prostate cancer remains one of the most common malignancies among men worldwide, with approximately 2,500 new cases diagnosed annually in Israel. Half of these are detected early, when radiation therapy is a highly effective treatment option. However, the current standard of five sessions requires significant time, preparation, and emotional resilience from patients.

Research conducted by doctors at the Davidoff Comprehensive Cancer Center at Beilinson Hospital in Petah Tikva demonstrated the feasibility and effectiveness of delivering high-dose external beam radiation therapy for prostate cancer in just two sessions, without compromising safety or outcomes.

“Reducing the number of radiation treatments from five to two can significantly ease the physical and emotional toll on patients, making the treatment process more tolerable,” said Dr. Elisha Fredman, who led the research. “Treating patients more efficiently also allows them to start therapy sooner, benefiting everyone involved.”